Literature DB >> 14710370

Bone microdamage and cell apoptosis.

B Noble1.   

Abstract

Accumulation of microdamage in bone leads to the reduced strength of our skeleton. In health, bone adapts to the prevailing mechanical needs of the organism and is also capable of self-repair, sensing, removing and replacing damaged or mechanically insufficient volumes of bone. In disease and old age these characteristics are reduced. In order to undertake both of the processes of functional adaptation and repair the bone resorbing and forming cells must be very accurately targeted to areas of physiological need. The mechanism by which cells are precisely targeted to areas requiring repair is both clinically relevant and poorly understood. The osteocyte has been assumed to play a role in sensing damage and signaling for its removal, due largely to its abundance throughout the mineralized bone matrix. However, until recently there has been little evidence that osteocyte function is modified in the vicinity of the microdamage. Here I outline the possibility that the targeted removal of bone containing microcracks might involve signals derived from the apoptotic death of the osteocyte. I shall discuss data that support or refute this view and will consider the possible molecular mechanisms by which controlled cell death might contribute to the signals for repair in the light of work involving cells in bone and other tissue systems.

Mesh:

Year:  2003        PMID: 14710370     DOI: 10.22203/ecm.v006a05

Source DB:  PubMed          Journal:  Eur Cell Mater        ISSN: 1473-2262            Impact factor:   3.942


  30 in total

1.  Preservation of femoral bone thickness in middle age predicts survival in genetically heterogeneous mice.

Authors:  Richard A Miller; Jaclynn Kreider; Andrzej Galecki; Steven A Goldstein
Journal:  Aging Cell       Date:  2011-03-22       Impact factor: 9.304

Review 2.  Osteocyte regulation of bone mineral: a little give and take.

Authors:  G J Atkins; D M Findlay
Journal:  Osteoporos Int       Date:  2012-08       Impact factor: 4.507

3.  Microcracks and osteoclast resorption activity in vitro.

Authors:  Monika Rumpler; Tanja Würger; Paul Roschger; Elisabeth Zwettler; Herwig Peterlik; Peter Fratzl; Klaus Klaushofer
Journal:  Calcif Tissue Int       Date:  2012-01-24       Impact factor: 4.333

Review 4.  The past, present, and future of bone morphometry: its contribution to an improved understanding of bone biology.

Authors:  Webster S S Jee
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

5.  Histomorphometric and osteocytic characteristics of cortical bone in male subtrochanteric femoral shaft.

Authors:  Xiaoyu Tong; Markus K H Malo; Inari S Burton; Jukka S Jurvelin; Hanna Isaksson; Heikki Kröger
Journal:  J Anat       Date:  2017-08-07       Impact factor: 2.610

6.  Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of β-catenin.

Authors:  K Jähn; N Lara-Castillo; L Brotto; C L Mo; M L Johnson; M Brotto; L F Bonewald
Journal:  Eur Cell Mater       Date:  2012-09-12       Impact factor: 3.942

7.  Osteoclasts prefer aged bone.

Authors:  K Henriksen; D J Leeming; I Byrjalsen; R H Nielsen; M G Sorensen; M H Dziegiel; T John Martin; C Christiansen; P Qvist; M A Karsdal
Journal:  Osteoporos Int       Date:  2007-01-10       Impact factor: 4.507

Review 8.  Advances in osteoclast biology resulting from the study of osteopetrotic mutations.

Authors:  T Segovia-Silvestre; A V Neutzsky-Wulff; M G Sorensen; C Christiansen; J Bollerslev; M A Karsdal; K Henriksen
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

9.  Loss of trabeculae by mechano-biological means may explain rapid bone loss in osteoporosis.

Authors:  Brianne M Mulvihill; Laoise M McNamara; Patrick J Prendergast
Journal:  J R Soc Interface       Date:  2008-10-06       Impact factor: 4.118

10.  If good things come from above, do bad things come from below?

Authors:  David M Findlay
Journal:  Arthritis Res Ther       Date:  2010-05-27       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.